Research & Development: Page 57
-
PharmaVoice Team/PharmaVoice
New Considerations for the Design and Execution of Immuno-Oncology Drug Trials
There is much excitement in the field of immuno-oncology drugs with the approval of sipuleucel-T (Provenge), ipilimumab (Yervoy), and the very promising data on other checkpoint modulators, new oncolytic viruses, and therapeutic vaccines on the horizon. There are some important adjustments in tre...
By Jeffrey Weisberg • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Top 10 Clinical Trial Cost-Cutting Innovations
The challenges associated with conducting and managing today’s clinical trials have never been greater. According to a recent survey, clinical trials today cost 60% more than they did five years ago. Primary cost drivers include trial site startup (i.e., training, systems setup and access, regula...
By Sandra R. Lottes • May 29, 2014 -
Explore the Trendline➔
Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
How Information Technology is Enhancing Clinical Trials Recruitment and Participation
New platforms and technology today are able to help keep the right physicians apprised of the right open trials — communicating information efficiently across multiple locations in a large geographical area. Pharmaceutical companies have long struggled to achieve clinical trial recruitment goals....
By Jeff Meehan • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Mapping Your Workforce Genome
What if you could plan out your workforce needs with the precision that we see in well-crafted R&D protocols and personalized medicine? And what if you could look at your human capital engagements and the available “talent supply chain" in the way science has started to look at sustaining hea...
By Mark A. Lanfear • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Data-Driven Approaches Accelerate Trial Recruitment and Quantify Risk
At one time, biopharmaceutical companies could develop their clinical trial recruitment strategies using nothing more than historical experience, anecdotal knowledge, and gut instinct. They could trust investigators to supply the necessary patients, and as a last resort, bolt on some media covera...
By Ramita Tandon • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Innovating Clinical Trials: Aggregating Clinical Data for Easy Access and Brilliant Insights
There are increasing pressures for life-sciences companies to look aggressively for ways to decrease costs and bring new products to market more quickly. Sponsors want to leverage their clinical data to support critical decisions. To do this clinical data need to be easily accessible and integrat...
By Raj Indupuri • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Why Investigators Hold the Cards to Clinical Trial Success
Why Investigators Hold the Cards to Clinical Trial Success “Including experienced investigators early in the process of writing a protocol would help prevent common issues that hinder trial enrollment and retention" said a clinical trial investigator from Jacksonville, Fla. Clinical trials demand...
By Dr. Claire Sears • May 29, 2014 -
PharmaVoice Team/PharmaVoice
The New Face of Informed Consent: It's More Than A Signature
Contributed by: Marc Sirockman, Executive Vice President & General Manager Artcraft Health and Lisa Moss Calderwood, MA, Senior Medical Writer, Artcraft Health Informed patients make for compliant participants, compliant participants deliver verifiable data. This equation leads to the deliver...
By Marc Sirockman • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Move Aside, Paper: Capturing Clinical trial Outcomes in the Digital Age
There has been much discussion throughout the healthcare industry about providing a positive patient experience and encouraging patients to have more of a voice in their treatment options. Stakeholders have come to recognize that patients have valuable information to share about their experiences...
By Mark Wade • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Thailand Makes Great Strides in Healthcare
With a growing pharmaceutical market, renowned biotechnology research programs, and strong government support for the industry, Thailand has much to recommend it to the global pharma industry. The Kingdom of Thailand, a country with a population of 70 million people, is regarded as newly industri...
By Kim Ribbink • May 29, 2014 -
PharmaVoice Team/PharmaVoice
2014 DIA Preview
2014 DIA Preview New tools, services, and products to improve drug development — as well as personnel appointments — from DIA exhibitors. This year marks the 50th Anniversary of the Annual Meeting of the Drug Information Association, the largest multidisciplinary event that brings together a glob...
By Taren Grom • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool executive appointments and promotions in the healthcare industry Pharma Pool DR. UDIT BATRA EMD Millipore Introduces CEO and President EMD Millipore, the life-sciences division of Merck KGaA, has appointed Udit Batra, Ph.D., as president and CEO, responsible for the organization’s str...
By Ann Grey • May 29, 2014 -
PharmaVoice Team/PharmaVoice
On the Calendar
The Calendar Industry Events and Conferences, including Special Discounts Coming Attractions This year marks the 50th Anniversary of the DIA Annual Meeting, the largest multidisciplinary event that brings together a global network of life-sciences professionals to foster innovation that will lead...
By Heather Hummel • May 29, 2014 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Spending on Compounded Medications More Than Doubled in 2013 Cost increases drive higher drug trend for worker’s compensation Significant increases in cost-per prescription drove drug trend for workers’ compensation payers higher in 2013, according to research by Express Scripts. Overall pharmacy...
By Denise Myshko • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
QualityHealth Develops Opt-In Program to Recruit Patients Trending Now: Clinical Trial Connection deepens patient recruitment insight and improves reach and conversion. QualityHealth has expanded its clinical trial recruitment services to include an advanced opt-in program, the QualityHealth Clin...
By Denise Myshko • May 29, 2014 -
PharmaVoice Team/PharmaVoice
What's New
Roska Healthcare Advertising Is Now PulseCX TrendIng Now: Customer experience is focus of rebranded agency. Roska Healthcare Advertising has changed its name and brand identity to PulseCX to capture the agency’s focus on the healthcare customer experience, or CX. “The ways in which customers and ...
By Ann Grey • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Malaysia Focuses on Growth with Healthcare a Top Priority
Malaysia presents an attractive market to pharmaceutical companies thanks to growing government support, good infrastructure, and a trusted manufacturing environment. Malaysia is a federal constitutional monarchy with a population of about 29 million and an open and growing economy. According to ...
By Kim Ribbink • April 28, 2014 -
PharmaVoice Team/PharmaVoice
HBA's 2014 Rising Stars
Joyce Acbay Senior Director, Regulatory Affairs Actelion Pharmaceuticals Joyce is passionate about mentoring women and helping others reach their professional goals. Lorrie Albinson Associate Director, Sales Training and Development Actavis Brand Sales Actavis Lorrie is a distinguished leader at ...
By Taren Grom • April 28, 2014 -
PharmaVoice Team/PharmaVoice
Data-Driven Patient Recruitment
New tools are being introduced to help pharmaceutical companies identify, screen, and retain patients in clinical trials. Patient recruitment delays and low-retention rates are key factors in increasing development costs. To optimize both recruitment and retention, there needs to be a plan based ...
By Denise Myshko • April 28, 2014 -
PharmaVoice Team/PharmaVoice
Last Word
Antibiotic Resistance Facts The CDC’s Action Plan Last Word Tackling Antibiotic Resistance Tom Lowery, Ph.D., Chief Scientific Officer, of T2 Biosystems, discusses the growing threat of antibiotic resistance. PV: Why is antibiotic resistance an issue? Lowery: Antibiotic resistance is something th...
By Tom Lowery • April 28, 2014 -
PharmaVoice Team/PharmaVoice
Talent Pool
By Ann Grey Pharma Pool Dr. William Pao Roche Names Industry Veteran to Lead Oncology Research Roche has named William Pao, M.D., Ph.D., professor of medicine and head of the hematology-oncology division at Vanderbilt University Medical Center, to Roche Pharma Research and Early Development (pRED...
By Ann Grey • April 28, 2014 -
PharmaVoice Team/PharmaVoice
PharmaTrax
New Technology is Driving Breakthroughs Trending now: Cloud-based applications, embedded analytics, and integrated systems are lowering pharma and payer costs and improving patient outcomes. Life-sciences companies are aggressively embracing new technology-driven approaches to commercialize their...
By Denise Myshko • April 28, 2014 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
New electronic and web-based applications, sites, and technologies Veeva Launches Communications Channel Trending Now: New Web-based channel enables life-sciences companies to interact with healthcare professionals online anytime, anywhere, and on any device. Veeva Systems has introduced Veeva ...
By Denise Myshko • April 28, 2014 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies Parexel Launches Regulatory Outsourcing Service Trending Now: Regulatory information management solutions to enhance client value. Parexel, a global biopharmaceutical services provider, has launched a new service line designed to provide a ...
By Ann Grey • April 28, 2014 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
Allergy Immunotherapy Without the Shots Jens Bager of ALK talks about the company’s allergy tablet, which addresses the specific substance causing the immune system to overreact. Allergies have become increasingly common worldwide and have a tendency to aggravate with time. Currently, more than 2...
By Jens Bager of ALK • April 28, 2014
Previous
